{
"info": {
"nct_id": "NCT00587431",
"official_title": "Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer",
"inclusion_criteria": "* Diagnosis of prostate adenocarcinoma histologically confirmed at MSKCC or SKCCC.\n* Patient must have a serum testosterone > 180 ng/dl.\n* Karnofsky performance status (KPS)>_70%.\n* Patients must have adequate organ function as defined by the following\n* laboratory criteria:\n* WBC >_ 3500/mm3\n* ANC >_1500/mm3\n* Platelet count >100,000/mm3\n* Hemoglobin >8.0g/dL\n* Creatinine <1.6mg/dl\n* Total Bilirubin WNL (unless due to Gilbert's disease and other LFTs are WNL)\n* SGOT and SGPT If alkaline phosphatase is _< 2.5 x ULN, any elevations in\n* AST/ALT; OR if AST/ALT is _<1.5 x ULN, any elevation in alkaline phos\n* Prior hormonal therapy is allowed as:\n\n 1. Neoadjuvant treatment prior to radiation therapy or radical pmstatectomy, provided that the total duration of therapy does not exceed 6 months (Proscar is not considered a hormone therapy).\n 2. One cycle of intermittent therapy up to a maximum exposure of 6 months (Proscar is not considered a hormone therapy).\n* Patients must be at least 18 years of age.\n* Patients must have signed an informed consent document stating that they understand the investigational nature of the proposed treatment\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Clinically significant cardiac disease (New York Heart Association Class III/IV), or severe debilitating pulmonary disease.\n* Uncontrolled serious active infection.\n* Anticipated survival of less than 3 months.\n* Active CNS or epiduraltumor\n* Inability or unwillingness to comply with the treatment protocol, follow-up, or research tests\n* Peripheral neuropathy >_ grade 3.\n* Patients with a history of severe hypersensitivity reaction to drugs formulated with polysorbate 80.\n* Men of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 6 months after completion of the treatment.\n* Prior chemotherapy\n* Concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital, St. Johns's Wort (hypericum perforatum) and ketoconazole is prohibited.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Diagnosis of prostate adenocarcinoma histologically confirmed at MSKCC or SKCCC.",
"criterions": [
{
"exact_snippets": "Diagnosis of prostate adenocarcinoma",
"criterion": "prostate adenocarcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "histologically confirmed",
"criterion": "histological confirmation",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "at MSKCC or SKCCC",
"criterion": "confirmation location",
"requirements": [
{
"requirement_type": "location",
"expected_value": [
"MSKCC",
"SKCCC"
]
}
]
}
]
},
{
"line": "* Patient must have a serum testosterone > 180 ng/dl.",
"criterions": [
{
"exact_snippets": "serum testosterone > 180 ng/dl",
"criterion": "serum testosterone",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 180,
"unit": "ng/dl"
}
}
]
}
]
},
{
"line": "* Karnofsky performance status (KPS)>_70%.",
"criterions": [
{
"exact_snippets": "Karnofsky performance status (KPS)>_70%",
"criterion": "Karnofsky performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
]
}
]
},
{
"line": "* Patients must have adequate organ function as defined by the following",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* laboratory criteria:",
"criterions": [
{
"exact_snippets": "laboratory criteria",
"criterion": "laboratory criteria",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "N/A"
}
]
}
]
},
{
"line": "* WBC >_ 3500/mm3",
"criterions": [
{
"exact_snippets": "WBC >_ 3500/mm3",
"criterion": "WBC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 3500,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* ANC >_1500/mm3",
"criterions": [
{
"exact_snippets": "ANC >_1500/mm3",
"criterion": "ANC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1500,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Platelet count >100,000/mm3",
"criterions": [
{
"exact_snippets": "Platelet count >100,000/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 100000,
"unit": "mm3"
}
}
]
}
]
},
{
"line": "* Hemoglobin >8.0g/dL",
"criterions": [
{
"exact_snippets": "Hemoglobin >8.0g/dL",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 8.0,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Creatinine <1.6mg/dl",
"criterions": [
{
"exact_snippets": "Creatinine <1.6mg/dl",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1.6,
"unit": "mg/dl"
}
}
]
}
]
},
{
"line": "* Total Bilirubin WNL (unless due to Gilbert's disease and other LFTs are WNL)",
"criterions": [
{
"exact_snippets": "Total Bilirubin WNL",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": "WNL"
}
]
},
{
"exact_snippets": "unless due to Gilbert's disease",
"criterion": "Gilbert's disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "other LFTs are WNL",
"criterion": "other liver function tests (LFTs)",
"requirements": [
{
"requirement_type": "level",
"expected_value": "WNL"
}
]
}
]
},
{
"line": "* AST/ALT; OR if AST/ALT is _<1.5 x ULN, any elevation in alkaline phos",
"criterions": [
{
"exact_snippets": "AST/ALT",
"criterion": "AST/ALT levels",
"requirements": [
{
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "any elevation in alkaline phos",
"criterion": "alkaline phosphatase levels",
"requirements": [
{
"requirement_type": "elevation",
"expected_value": true
}
]
}
]
},
{
"line": "* Prior hormonal therapy is allowed as:",
"criterions": [
{
"exact_snippets": "Prior hormonal therapy is allowed",
"criterion": "prior hormonal therapy",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
}
]
},
{
"line": "1. Neoadjuvant treatment prior to radiation therapy or radical pmstatectomy, provided that the total duration of therapy does not exceed 6 months (Proscar is not considered a hormone therapy).",
"criterions": [
{
"exact_snippets": "Neoadjuvant treatment prior to radiation therapy or radical pmstatectomy",
"criterion": "neoadjuvant treatment",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "prior to radiation therapy or radical pmstatectomy"
}
]
},
{
"exact_snippets": "total duration of therapy does not exceed 6 months",
"criterion": "total duration of therapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "2. One cycle of intermittent therapy up to a maximum exposure of 6 months (Proscar is not considered a hormone therapy).",
"criterions": [
{
"exact_snippets": "One cycle of intermittent therapy",
"criterion": "intermittent therapy cycle",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": true
}
]
},
{
"exact_snippets": "maximum exposure of 6 months",
"criterion": "therapy exposure duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Patients must be at least 18 years of age.",
"criterions": [
{
"exact_snippets": "Patients must be at least 18 years of age.",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patients must have signed an informed consent document stating that they understand the investigational nature of the proposed treatment",
"criterions": [
{
"exact_snippets": "signed an informed consent document",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
},
{
"exact_snippets": "stating that they understand the investigational nature of the proposed treatment",
"criterion": "understanding of investigational nature",
"requirements": [
{
"requirement_type": "understanding",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Clinically significant cardiac disease (New York Heart Association Class III/IV), or severe debilitating pulmonary disease.",
"criterions": [
{
"exact_snippets": "Clinically significant cardiac disease (New York Heart Association Class III/IV)",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "New York Heart Association Class III/IV"
}
]
},
{
"exact_snippets": "severe debilitating pulmonary disease",
"criterion": "pulmonary disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe debilitating"
}
]
}
]
},
{
"line": "* Uncontrolled serious active infection.",
"criterions": [
{
"exact_snippets": "Uncontrolled serious active infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
},
{
"requirement_type": "severity",
"expected_value": "serious"
},
{
"requirement_type": "activity",
"expected_value": true
}
]
}
]
},
{
"line": "* Anticipated survival of less than 3 months.",
"criterions": [
{
"exact_snippets": "Anticipated survival of less than 3 months.",
"criterion": "anticipated survival",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Inability or unwillingness to comply with the treatment protocol, follow-up, or research tests",
"criterions": [
{
"exact_snippets": "Inability or unwillingness to comply with the treatment protocol",
"criterion": "compliance with treatment protocol",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness to comply with ... follow-up",
"criterion": "compliance with follow-up",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness to comply with ... research tests",
"criterion": "compliance with research tests",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Peripheral neuropathy >_ grade 3.",
"criterions": [
{
"exact_snippets": "Peripheral neuropathy >_ grade 3",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "grade"
}
}
]
}
]
},
{
"line": "* Patients with a history of severe hypersensitivity reaction to drugs formulated with polysorbate 80.",
"criterions": [
{
"exact_snippets": "history of severe hypersensitivity reaction to drugs formulated with polysorbate 80",
"criterion": "hypersensitivity reaction to polysorbate 80",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Men of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 6 months after completion of the treatment.",
"criterions": [
{
"exact_snippets": "Men of childbearing potential",
"criterion": "gender and reproductive potential",
"requirements": [
{
"requirement_type": "gender",
"expected_value": "male"
},
{
"requirement_type": "reproductive potential",
"expected_value": "childbearing"
}
]
},
{
"exact_snippets": "willing to consent to using effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "consent",
"expected_value": true
}
]
},
{
"exact_snippets": "while on treatment and for at least 6 months after completion of the treatment",
"criterion": "contraception duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "while on treatment and for at least 6 months after completion of the treatment"
}
]
}
]
},
{
"line": "* Prior chemotherapy",
"criterions": [
{
"exact_snippets": "Prior chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
}
]
},
{
"line": "* Concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital, St. Johns's Wort (hypericum perforatum) and ketoconazole is prohibited.",
"criterions": [
{
"exact_snippets": "Concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital, St. Johns's Wort (hypericum perforatum) and ketoconazole is prohibited.",
"criterion": "concomitant use of specific substances",
"requirements": [
{
"requirement_type": "prohibition",
"expected_value": [
"phenytoin",
"carbamazepine",
"barbiturates",
"rifampicin",
"phenobarbital",
"St. Johns's Wort (hypericum perforatum)",
"ketoconazole"
]
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* SGOT and SGPT If alkaline phosphatase is _< 2.5 x ULN, any elevations in",
"criterions": [
{
"exact_snippets": "SGOT and SGPT",
"criterion": "SGOT and SGPT",
"requirements": [
{
"requirement_type": "elevation",
"expected_value": "allowed if alkaline phosphatase is < 2.5 x ULN"
}
]
},
{
"exact_snippets": "alkaline phosphatase is < 2.5 x ULN",
"criterion": "alkaline phosphatase",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
}
],
"failed_exclusion": [
{
"line": "* Active CNS or epiduraltumor",
"criterions": [
{
"exact_snippets": "Active CNS or epidural tumor",
"criterion": "CNS tumor",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
},
{
"exact_snippets": "Active CNS or epidural tumor",
"criterion": "epidural tumor",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}